SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) (Frankfurt: XMPA) is voluntarily delisting from the Frankfurt Stock Exchange (FSE). The move is primarily in response to the significant shift in trading volume since December 2005 from the FSE toward the NASDAQ Global Market, where Cytori will maintain its primary listing. Cytori’s last day of trading on the FSE will be September 25, 2007. Following this date, shares owned in Germany, the United States, or elsewhere may continue to be traded through the NASDAQ Global Market under the symbol CYTX.
